Subsequently, we determined that ARPC1A was predominantly present in the cell junctions and cytoplasm by immunofluorescence in A-431 (human epidermoid carcinoma cell line) and MCF-7 (human breast cancer cells) (Figures 2E and S2B). Here, ARPC1A is linked to breast cancer.